Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Oxycodone. Photo: Education Images/UIG via Getty Images
Rochester Drug Cooperative may become the first major drug distributor to face criminal charges over the opioid epidemic, the New York Times reports.
What's happening: The Southern District of New York and the Drug Enforcement Agency are wrapping up an investigation that began with an examination of potential crimes that included fraud and drug violations. It's unclear what charges would be brought against Rochester.
The big picture: Other major distributors are involved in other civil lawsuits across the country.
- They allege that distributors created systems to evade regulators as they continued to shuttle around massive amounts of opioids.
The bottom line: The three largest distributors failed to adequately monitor suspicious opioid orders at the onset of the epidemic, and have since failed to build systems that prevent abuse, the NYT writes.
- These distributors — Cardinal Health, McKesson and AmerisourceBergen — sold 1.6 billion oxycodone pills in New York between 2010 and 2018.
Go deeper: